• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Emergent BioSolutions Reports Q3 2024 Financial Results

    GLOBENEWSWIRE

    Emergent BioSolutions Supports Brincidofovir Mpox Trial in Africa

    GLOBENEWSWIRE

    Emergent BioSolutions Appoints Dr. Simon Lowry as CMO

    GLOBENEWSWIRE

    Emergent BioSolutions Q3 2024 Results and Call on November 6

    GLOBENEWSWIRE

    Emergent Demonstrates Commitment To NARCAN Access

    GLOBENEWSWIRE

    Emergent BioSolutions Closes $100M Asset-Backed Loan Facility

    GLOBENEWSWIRE

    Emergent BioSolutions Executes Contract Options For TEMBEXA

    GLOBENEWSWIRE

    Emergent BioSolutions` mpox preparedness orders reach $400M

    FIERCE PHARMA

    Emergent Confirms $400M In Smallpox And Mpox Orders

    GLOBENEWSWIRE

    Emergent BioSolutions Settles Securities Class Action Litigation

    GLOBENEWSWIRE

    Emergent BioSolutions Awarded $41.9M For Ebanga Ebola Treatment

    GLOBENEWSWIRE

    Emergent BioSolutions Refinances Debt, Strengthens Financial Profile

    GLOBENEWSWIRE

    Emergent BioSolutions Expands Ready To Rescue Opioid Emergency Initiative

    GLOBENEWSWIRE

    US FDA approves Emergent`s smallpox vaccine for people at high risk of mpox

    REUTERS

    Bora Completes Acquisition of US Sterile Fill/Finish Facility From Emergent

    PRESS RELEASE

    Emergent joins broader efforts for mpox vaccine drive in Africa

    ENDPTS

    Emergent BioSolutions Responds To Mpox Emergency As Cases Rise In Africa

    GLOBENEWSWIRE

    Emergent BioSolutions Expands NARCAN® Nasal Spray Distribution

    GLOBENEWSWIRE

    Emergent BioSolutions Reports Second Quarter 2024 Financial Results

    GLOBENEWSWIRE

    Emergent BioSolutions Sells RSDL® Kit To SERB For $75 Million

    GLOBENEWSWIRE

    Emergent BioSolutions Launches Opioid Emergency Campaign With Emmitt Smith

    GLOBENEWSWIRE

    Emergent, ex-NFL star show how to tackle opioid overdoses in new ad blitz

    FIERCE PHARMA

    Emergent BioSolutions To Release Q2 2024 Results On August 6

    GLOBENEWSWIRE

    Emergent BioSolutions Extends Shelf-Life For NARCAN Spray In Canada

    GLOBENEWSWIRE

    US FDA declines to approve Orexo`s opioid overdose drug

    REUTERS

    Emergent BioSolutions Continues Multi-Year Transformation Plan

    GLOBENEWSWIRE

    Emergent, J&J settle COVID vaccine supply deal dispute

    REUTERS

    Emergent BioSolutions Awarded $250M+ For Medical Countermeasure Products

    GLOBENEWSWIRE

    Emergent bags $250M in contract modifications to help boost US supply

    FIERCE PHARMA

    Emergent BioSolutions Sells Baltimore-Camden Site To Bora Pharma For $30M

    PRESS RELEASE

    Emergent Drives Progress Against Opioid Epidemic On Naloxone Day

    GLOBENEWSWIRE

    Emergent BioSolutions Virtual Stockholder Meeting On May 23

    GLOBENEWSWIRE

    Survey Shows Need For Expanded Naloxone Access, Awareness

    GLOBENEWSWIRE

    Emergent Bio Announces Strategic Operational Changes

    GLOBENEWSWIRE

    Emergent BioSolutions Reports First Quarter 2024 Financial Results

    GLOBENEWSWIRE

    Emergent to cut 300 jobs, shutter 2 facilities in major overhaul

    FIERCE PHARMA

    Emergent BioSolutions Announces Amendment to its Existing Credit Facility

    GLOBENEWSWIRE

    Emergent Bio Q1 2024 Results, Call On May 1

    GLOBENEWSWIRE

    Emergent Continues to Awareness and Availability of NARCAN® Nasal Spray

    GLOBENEWSWIRE

    Emergent Receives NAI Status for Baltimore Bayview Manufacturing Facility

    GLOBENEWSWIRE

    Emergent BioSolutions Reports Fourth Quarter 2023 Financial Results

    GLOBENEWSWIRE

    Emergent Bio to Release Fourth Quarter & Full Year 2023 Financial Results

    GLOBENEWSWIRE

    Emergent snares $235.8M US contract to supply anthrax vaccine

    FIERCE PHARMA

    Emergent BioSolutions Awarded Procurement Contract Valued up to $235.8 Million

    GLOBENEWSWIRE

    Emergent nabs US government contract of up to $235.8M for anthrax vaccine 

    ENDPTS

    Emergent Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference

    GLOBENEWSWIRE

    Emergent lines up BARDA pact to supply anthrax shot in the US

    FIERCE PHARMA

    Emergent BioSolutions Receives NYSE Notice Regarding Delayed Form 10-Q Filing

    GLOBENEWSWIRE

    Emergent BioSolutions Reports Third Quarter 2023 Financial Results

    GLOBENEWSWIRE

    UPDATE: Emergent BioSolutions to Release Third Quarter 2023 Financial Results

    GLOBENEWSWIRE

    Emergent BioSolutions to Release Third Quarter 2023 Financial Results

    GLOBENEWSWIRE

    Emergent taps ex-NFL star to bring opioid message to tailgates

    FIERCE PHARMA

    Emergent BioSolutions Partners with Emmitt Smith

    PR NEWSWIRE

    Emergent Names Two Pharmaceutical Industry Veterans to Board of Directors

    GLOBENEWSWIRE

    Emergent BioSolutions’ NARCAN® Nasal Spray Launches Over the Counter Making

    GLOBENEWSWIRE

    Emergent BioSolutions to lay off about 400 employees

    REUTERS

    Emergent BioSolutions Announces Strategic Steps to Strengthen Financial Position

    GLOBENEWSWIRE

    Emergent BioSolutions Reports Financial Results for Second Quarter 2023

    GLOBENEWSWIRE

    BARDA awards Emergent 10-year, $704M contract for Ebola treatment

    ENDPTS

    Emergent Awarded 10-Year BARDA Contract Valued at up to a Maximum of $704M

    GLOBENEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.